MEDICAL DECISION SUPPORT SOFTWARE BUSINESS PLAN

I. Executive Summary

Company Description

The company (hereafter "the Company") is a United States–based healthcare technology firm focused on AI-driven clinical decision support. The name is not provided; the Company’s origin is a U.S. incorporation serving hospital systems and multi-specialty clinics. We build a cloud-native platform that delivers real-time predictive analytics and alerts by ingesting EHR, device, and lab feeds. One-liner: we turn complex patient data into actionable predictions at the point of care.

Our core products are predictive modules and an integration layer that plugs into existing hospital infrastructure with HL7/FHIR connectors, role-based clinician dashboards, and API-first deployment. Main activities include model development, clinical validation with health-system partners, enterprise deployment, and 24/7 support. We compete on clinical-grade accuracy, low-latency integration, and turnkey operations. Target customers are large hospital systems and multi-specialty clinics managing high-acuity caseloads. Short-term goal: complete three enterprise pilots and achieve SOC 2 by Q4 2026. Long-term goal: nationwide enterprise penetration and FDA-cleared predictive modules. One-liner: we sell predictive insights that reduce adverse events and operational cost for large care providers.

Problem

Healthcare providers face rampant clinician burnout and rising diagnostic errors driven by cognitive overload from excessive patient data and fragmented administrative workflows. Non-actionable alerts, slow decision-making, and time spent on clerical tasks leave clinicians unable to reliably prioritize high-risk cases, increasing avoidable patient harm and financial loss for large hospital systems and multispecialty clinics.

Existing clinical systems are rigid and fail to deliver real-time, prioritized, actionable insights at the point of care, leaving a persistent gap in tools that filter noise and surface high-risk scenarios. This gap creates a clear need for an integrated, AI-driven clinical decision support layer that converts complex data into timely, usable guidance for care teams.

Solution

Healthcare teams face cognitive overload from massive data and admin work, driving burnout, diagnostic errors, and inefficiency. Our intelligent clinical decision support platform integrates with Electronic Health Records via HL7/FHIR-compatible APIs to deliver real-time, patient-specific predictive alerts and evidence-based treatment guidance inline with clinicians’ workflow, using machine learning that synthesizes vitals, labs, medications, and notes.

One-liner: real-time, EHR-embedded predictive alerts and treatment guidance.

Mission Statement

We empower healthcare providers with AI-driven tools that enable faster, smarter, and more accurate clinical decisions. We reduce clinician burnout and improve patient outcomes by integrating predictive analytics into daily workflows while upholding strict data security and privacy standards. We partner with hospital systems to deliver operational excellence and measurable clinical quality improvements for all patients.

Key Success Factors

Success rests on deep EHR integration, superior predictive models, strict compliance, scalable team capacity, and disciplined finance.

• Deep technical integration with major EHR vendors ensures high adoption and low workflow friction.
• Proprietary machine learning models deliver predictive accuracy above legacy systems.
• HIPAA compliance and robust data security build trust with large healthcare institutions.
• Scalable specialist team (6 to 19 FTEs) enables national customer support and faster onboarding.
• Disciplined financial management targets an 11-month path to breakeven and sustained profitability.

Financial Summary

Financial summary for the Executive Summary: five-year revenue growth from $1.439M in 2026 to $13.122M in 2030, with rapid path to profitability.

Financial requirements: initial capex $200,000 and minimum cash buffer $446,000 (minimum cash month Jan-27). Anticipated returns: IRR 7.67% and ROE 13.19%; breakeven Nov-26 and payback in 27 months.

Overall outlook: strong revenue scaling, breakeven within the first year, and positive investor returns by year five.

Funding Requirements

The company seeks $1,948,000 to fund 2026 CapEx, first-year operating shortfall, a $150,000 marketing program, staffing for the specialized data science and engineering team, and a $446,000 minimum cash reserve, supporting a revenue ramp from $1.439M in 2026 to $13.122M in 2030, breakeven in Nov-2026, 27-month payback, 7.67% IRR and 13.19% ROE.